Reply to Tomasz Drewa and Piotr Chlosta's Letter to the Editor re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate. Eur Urol 2009;56:237-44 Journal Article

  

Authors:	Morris, M. J.; Scher, H. I.
Article Title:	Reply to Tomasz Drewa and Piotr Chlosta's Letter to the Editor re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate. Eur Urol 2009;56:237-44
Keywords:	clinical trial; drug safety; unspecified side effect; drug megadose; outcome assessment; letter; biological marker; gene overexpression; metastasis; cancer cell culture; risk assessment; prostate cancer; androgen receptor; phase 1 clinical trial; castration; testosterone; drug exposure
Journal Title:	European Urology
Volume:	57
Issue:	2
ISSN:	0302-2838
Publisher:	Elsevier Science, Inc.
Date Published:	2010-02-01
Start Page:	e20
Language:	English
DOI:	10.1016/j.eururo.2009.10.022
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-72149134622&partnerID=40&md5=2db29619fd3c91d0d4d730e7da52c529
Notes:	--- - "Export Date: 20 April 2011" - "CODEN: EUURA" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/4663